Cargando…
Inhibition of Immune Complex Complement Activation and Neutrophil Extracellular Trap Formation by Peptide Inhibitor of Complement C1
Two major aspects of systemic lupus erythematosus (SLE) pathogenesis that have yet to be targeted therapeutically are immune complex-initiated complement activation and neutrophil extracellular trap (NET) formation by neutrophils. Here, we report in vitro testing of peptide inhibitor of complement C...
Autores principales: | Hair, Pamela S., Enos, Adrianne I., Krishna, Neel K., Cunnion, Kenji M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879100/ https://www.ncbi.nlm.nih.gov/pubmed/29632531 http://dx.doi.org/10.3389/fimmu.2018.00558 |
Ejemplares similares
-
Inhibition of complement activation, myeloperoxidase, NET formation and oxidant activity by PIC1 peptide variants
por: Hair, Pamela S., et al.
Publicado: (2019) -
Peptide Inhibitor of Complement C1 Inhibits the Peroxidase Activity of Hemoglobin and Myoglobin
por: Hair, Pamela S., et al.
Publicado: (2017) -
Peptide inhibition of neutrophil-mediated injury after in vivo challenge with supernatant of Pseudomonas aeruginosa and immune-complexes
por: Enos, Adrianne, et al.
Publicado: (2021) -
Inhibition of Myeloperoxidase Activity in Cystic Fibrosis Sputum by Peptide Inhibitor of Complement C1 (PIC1)
por: Hair, Pamela S., et al.
Publicado: (2017) -
Peptide Inhibitor of Complement C1, a Novel Suppressor of Classical Pathway Activation: Mechanistic Studies and Clinical Potential
por: Sharp, Julia A., et al.
Publicado: (2014)